A detailed history of Global Retirement Partners, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Global Retirement Partners, LLC holds 8 shares of LGND stock, worth $829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$829
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$49.57 - $72.63 $396 - $581
8 New
8 $0
Q1 2022

Jul 14, 2022

BUY
$94.99 - $151.56 $379 - $606
4 New
4 $0
Q4 2018

Feb 22, 2019

SELL
$128.36 - $272.13 $5,904 - $12,517
-46 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$150.77 - $207.98 $6,935 - $9,567
46 New
46 $10,000
Q1 2018

Aug 10, 2018

SELL
$138.63 - $182.62 $3,604 - $4,748
-26 Closed
0 $0
Q4 2017

Aug 13, 2018

BUY
$128.36 - $147.04 $3,337 - $3,823
26
26 $4,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.75B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.